Oklahoma Life Science Fund

Cadenza Bio is a biotechnology company focused on the development of highly selective small-molecule drugs aimed at treating demyelinating and inflammatory diseases. The company is dedicated to creating therapeutic medications that not only alleviate symptoms but also halt disease progression, promote repair, and restore the quality of life for patients. By advancing a new class of Estrogen Receptor targeted small molecules, Cadenza Bio aims to empower patients to regain control over their health and improve their overall well-being.

Mate Fertility is a technology-driven fertility clinic founded in 2020 and based in Los Angeles, California. The company aims to make parenthood more accessible by providing comprehensive fertility services at affordable prices. It operates a platform that connects patients to fertility clinics and offers telemedicine options for various treatments and therapies. By delivering end-to-end fertility services, Mate Fertility ensures that patients receive expert guidance and care throughout their fertility journey, making the process more comfortable and manageable.

Access Optics is able to combine innovating manufacturing engineering, process development, and optical fabrication with advanced coating technology. The pioneering product development and advanced materials solutions have fostered breakthrough products for leading OEMs in endoscopy, dermatology, aerospace, and chromatography.

Recuro Health is a developer of an integrated digital health platform that aims to transform the U.S. healthcare system from a reactive, disease-focused model to one centered on population health and outcomes. The company provides a tailored Digital Medical Home that caters to specific healthcare needs, offering essential virtual care services, including primary care, behavioral health, and urgent care. By equipping employers, providers, and managed care organizations with various digital tools, education, and guidance, Recuro Health enables patients to actively engage in their healthcare through health assessments and interactive communication with professionals, whether via messaging or video. This approach seeks to enhance patient involvement and improve health outcomes across diverse settings.

Recuro Health is a developer of an integrated digital health platform that aims to transform the U.S. healthcare system from a reactive, disease-focused model to one centered on population health and outcomes. The company provides a tailored Digital Medical Home that caters to specific healthcare needs, offering essential virtual care services, including primary care, behavioral health, and urgent care. By equipping employers, providers, and managed care organizations with various digital tools, education, and guidance, Recuro Health enables patients to actively engage in their healthcare through health assessments and interactive communication with professionals, whether via messaging or video. This approach seeks to enhance patient involvement and improve health outcomes across diverse settings.

AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.

AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.